Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Preclinical CRO Global Market Report 2025
Request Sample Buy Now
Global Preclinical CRO Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Preclinical CRO Global Market Report 2025

By Service (Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services), By Type (Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model), By Animal Model (Small Animal Model, Large Animal Model), By Model System (In Vivo, In Vitro), By End User (Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Preclinical CRO Market Overview

• Preclinical CRO market size has reached to $5.7 billion in 2024

• Expected to grow to $8.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%

• Growth Driver: Surging Demand For Preclinical Trials Drives Growth In The Preclinical CRO Market

• Market Trend: Revolutionizing Preclinical Drug Discovery

• North America was the largest region in 2024.

What Is Covered Under Preclinical CRO Market?

Preclinical CROs (contract research organizations) are support organizations that provide the knowledge in research and development needed to guide a drug candidate through animal testing and advance it to the clinical stage. A preclinical CRO supports new medical product producers in showing product safety and efficacy in living animals that the Food and Drug Administration (FDA) considers mirroring human anatomy most closely before entering clinical trials or being used for human care.

The main services of preclinical CRO are bioanalysis and DMPK studies, Toxicology Testing, compound management, chemistry, safety pharmacology, and others. A small three-dimensional (3D) cell culture made from a patient's cancer cells is known as a patient-derived organoid (PDO), and it has undergone substantial investment and experimental validation to offer prospective therapeutic alternatives for the diagnosis of complex diseases. The various types of preclinical CRO including the patient-derived organoid (PDO) model and the patient-derived xenograft model are available for small animal and large animal models. The model systems In Vivo and In Vitro are used by biopharmaceutical companies, government and academic institutes, medical device companies, and others.

Preclinical CRO Market Size and growth rate 2025 to 2029: Graph

What Is The Preclinical CRO Market Size 2025 And Growth Rate?

The preclinical CRO market size has grown strongly in recent years. It will grow from$5.7 billion in 2024 to $6.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to demand for faster drug development, cost containment strategies, focus on core competencies, regulatory compliance requirements, globalization of clinical trials

What Is The Preclinical CRO Market Growth Forecast?

The preclinical CRO market size is expected to see strong growth in the next few years. It will grow to $8.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rise in personalized medicine, focus on rare diseases and orphan drugs, increased outsourcing in biopharmaceuticals, emphasis on biomarker research, demand for real-world evidence generation. Major trends in the forecast period include integration of artificial intelligence (AI), expansion of oncology research, advances in omics technologies, advanced in vitro and in vivo models, collaboration for translational research.

The forecast of 9.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biotech firms by driving up the cost of outsourced toxicology studies and pharmacokinetic testing sourced from India and the UK, exacerbating trial budgets and delaying regulatory submissions. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Preclinical CRO Market Segmented?

1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services

2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model

3) By Animal Model: Small Animal Model, Large Animal Model

4) By Model System: In Vivo, In Vitro

5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users

Subsegments:

1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies

2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing

3) By Compound Management: Sample Management, Inventory Management, Formulation Services

4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry

5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies

6) By Other Services: Regulatory Consulting, Project Management, Data Management Services

What Is Driving The Preclinical CRO Market? Surging Demand For Preclinical Trials Drives Growth In The Preclinical CRO Market

The increasing demand for preclinical trials is expected to propel the growth of the preclinical CRO market going forward. Preclinical trials refer to any study conducted on medicine or treatment for a condition before human volunteers are used as test subjects. Preclinical studies often involve novel medical devices, prescription medications, and diagnostics, and its primary objectives are to establish a beginning, safe dose for first-in-human research and evaluate any potential toxicity of the product. Preclinical trials play a critical role in drug development, and their importance is increasing with the growing emphasis on the safety and efficacy of new drugs. For instance, in February 2024, according to IQVIA, a US-based company serving the combined industries of health information technology and clinical research reports, clinical development productivity rose in 2023, where a total of 69 novel active substances (NASs) were launched globally in 2023, 6 more than the prior year, and including 24 first-in-class launches in the U.S. Therefore, the increasing demand for preclinical trials is driving the growth of the preclinical CRO industry going forward.

What Is Driving The Preclinical CRO Market? The Surge In Preclinical CRO Market Growth Through Outsourcing Services

The growing demand for outsourcing services is expected to propel the growth of the preclinical CRO market going forward. Outsourcing services refer to the practice of contracting with a third-party vendor to manage specific business tasks or operations. Preclinical research is becoming increasingly complex, requiring specialized skills and expertise that not all pharmaceutical and biotechnology companies have in-house. Outsourcing to preclinical CROs allows companies to access the expertise they need without investing in building capabilities and focus on core business while still getting the preclinical research done. For instance, in April 2023, according to a survey of 207 biopharma respondents and 138 suppliers by BioPlan Associates Inc., a US-based provider of independent strategic information and analysis, around 84.6% of biomanufacturers are outsourcing the analytical testing, and 74.5% of biomanufacturers are outsourcing for toxicity testing in 2023. Therefore, the growing demand for outsourcing services is driving the growth of the preclinical CRO industry.

Who Are The Major Players In The Global Preclinical CRO Market?

Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited

What Are The Key Trends Of The Global Preclinical CRO Market? Revolutionizing Preclinical Drug Discovery

Technological advancements are a key trend gaining popularity in the preclinical CRO market. Major companies operating in the preclinical CRO market are adopting new technologies to sustain their position in the market. For instance, in February 2023, BenchSci, a Canada-based AI solutions company for preclinical R&D, launched ASCEND, an end-to-end SaaS (software as a service) platform and for preclinical drug discovery. By gaining biological insights into the fundamental underpinnings of disease, this method seeks to speed up preclinical phase drug development pipelines. ASCEND extracts experimental data from safe internal and public external sources using BenchSci's machine-learning technology. The platform compares experimental results using curated ontology datasets. As a result, the software can produce a map of the biological processes underpinning various diseases that are based on evidence.

What Are The Key Trends Of The Global Preclinical CRO Market? Strategic Collaboration In Preclinical Cros

Major companies operating in the preclinical CRO are focused on collaboration and partnerships to provide reliable services to customers. A strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, in February 2022, IonsGate Preclinical Services Inc., a Canada-based CRO providing preclinical research services, announced a partnership with Insilicotrials Technologies Srl, an Italy-based provider of specialized consultancy for clinical trial solutions, to leverage innovative technology and accelerate drug discovery. The partnership allows for more comprehensive preclinical testing, which can help to identify potential safety risks earlier in the development process.

Need data on a specific region in this market?
Request Customisation

Preclinical CRO Market Merger And Acquisition: Asahi Kasei Medical Broadens Bioprocess Portfolio Through Strategic Acquisition Of Bionova Scientific LLC

In June 2022, Asahi Kasei Medical Co. Ltd., a Japan-based chemical company, acquired Bionova Scientific LLC for an undisclosed amount. With the acquisition of Bionova Scientific, Asahi Kasei Medical will be able to expand its bioprocess business by adding a biopharmaceutical CDMO (contract development and manufacturing organization) and reaching a broader customer base, including those developing the most cutting-edge next-generation biopharmaceuticals. Bionova Scientific LLC is a US-based company that offers biopharmaceutical firms contract process development services and GMP-compliant contract manufacturing services.

Regional Analysis For The Global Preclinical CRO Market

North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Preclinical CRO Market?

The preclinical CRO market includes revenues earned by entities through project management, information gathering, medical evaluations, maximum dose research, adherence to regulations, efficacy and safety reporting, and quality analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Preclinical CRO Industry?

The preclinical cro market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical cro industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Preclinical CRO Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $6.25 billion
Revenue Forecast In 2034 $8.99 billion
Growth Rate CAGR of 9.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users Subsegments: 1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing
3) By Compound Management: Sample Management, Inventory Management, Formulation Services
4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies 6) By Other Services: Regulatory Consulting, Project Management, Data Management Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Preclinical CRO Market Characteristics

3. Preclinical CRO Market Trends And Strategies

4. Preclinical CRO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Preclinical CRO Growth Analysis And Strategic Analysis Framework

5.1. Global Preclinical CRO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Preclinical CRO Market Growth Rate Analysis

5.4. Global Preclinical CRO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Preclinical CRO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Preclinical CRO Total Addressable Market (TAM)

6. Preclinical CRO Market Segmentation

6.1. Global Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bioanalysis and DMPK Studies

Toxicology Testing

Compound Management

Chemistry

Safety Pharmacology

Other Services

6.2. Global Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Patient Derived Organoid (PDO) Model

Patient Derived Xenograft Model

6.3. Global Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Animal Model

Large Animal Model

6.4. Global Preclinical CRO Market, Segmentation By Model System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In Vivo

In Vitro

6.5. Global Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biopharmaceutical Companies

Government and Academic Institutes

Medical Device Companies

Other End-users

6.6. Global Preclinical CRO Market, Sub-Segmentation Of Bioanalysis and DMPK Studies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmacokinetics Studies

Pharmacodynamics Studies

Drug Metabolism Studies

6.7. Global Preclinical CRO Market, Sub-Segmentation Of Toxicology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Toxicity Testing

Chronic Toxicity Testing

Reproductive Toxicity Testing

6.8. Global Preclinical CRO Market, Sub-Segmentation Of Compound Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sample Management

Inventory Management

Formulation Services

6.9. Global Preclinical CRO Market, Sub-Segmentation Of Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medicinal Chemistry

Analytical Chemistry

Synthetic Chemistry

6.10. Global Preclinical CRO Market, Sub-Segmentation Of Safety Pharmacology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiovascular Safety Studies

Central Nervous System Safety Studies

Respiratory Safety Studies

6.11. Global Preclinical CRO Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Regulatory Consulting

Project Management

Data Management Services

7. Preclinical CRO Market Regional And Country Analysis

7.1. Global Preclinical CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Preclinical CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preclinical CRO Market

8.1. Asia-Pacific Preclinical CRO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Preclinical CRO Market

9.1. China Preclinical CRO Market Overview

9.2. China Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Preclinical CRO Market

10.1. India Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Preclinical CRO Market

11.1. Japan Preclinical CRO Market Overview

11.2. Japan Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Preclinical CRO Market

12.1. Australia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Preclinical CRO Market

13.1. Indonesia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Preclinical CRO Market

14.1. South Korea Preclinical CRO Market Overview

14.2. South Korea Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Preclinical CRO Market

15.1. Western Europe Preclinical CRO Market Overview

15.2. Western Europe Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Preclinical CRO Market

16.1. UK Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Preclinical CRO Market

17.1. Germany Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Preclinical CRO Market

18.1. France Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Preclinical CRO Market

19.1. Italy Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Preclinical CRO Market

20.1. Spain Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Preclinical CRO Market

21.1. Eastern Europe Preclinical CRO Market Overview

21.2. Eastern Europe Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Preclinical CRO Market

22.1. Russia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Preclinical CRO Market

23.1. North America Preclinical CRO Market Overview

23.2. North America Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Preclinical CRO Market

24.1. USA Preclinical CRO Market Overview

24.2. USA Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Preclinical CRO Market

25.1. Canada Preclinical CRO Market Overview

25.2. Canada Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Preclinical CRO Market

26.1. South America Preclinical CRO Market Overview

26.2. South America Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Preclinical CRO Market

27.1. Brazil Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Preclinical CRO Market

28.1. Middle East Preclinical CRO Market Overview

28.2. Middle East Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Preclinical CRO Market

29.1. Africa Preclinical CRO Market Overview

29.2. Africa Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Preclinical CRO Market Competitive Landscape And Company Profiles

30.1. Preclinical CRO Market Competitive Landscape

30.2. Preclinical CRO Market Company Profiles

30.2.1. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.2. PRA Health Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Wuxi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Medpace Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Preclinical CRO Market Other Major And Innovative Companies

31.1. Laboratory Corporation of America Holdings

31.2. SGA SA

31.3. Intertek Group plc

31.4. Crown Bioscience International

31.5. Cynbiose

31.6. AmplifyBio LLC

31.7. Vivotecnia SL

31.8. Simavita Ltd.

31.9. BioEmission Technology Solutions

31.10. Altasciences Company Inc.

31.11. Global Center For Medical Innovation

31.12. Pharmaceutical Product Development LLC

31.13. Parexel International Corporation

31.14. Envigo RMS Holding Corporation

31.15. Veeda Clinical Research Ltd.

32. Global Preclinical CRO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preclinical CRO Market

34. Recent Developments In The Preclinical CRO Market

35. Preclinical CRO Market High Potential Countries, Segments and Strategies

35.1 Preclinical CRO Market In 2029 - Countries Offering Most New Opportunities

35.2 Preclinical CRO Market In 2029 - Segments Offering Most New Opportunities

35.3 Preclinical CRO Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Preclinical CRO Market, Segmentation By Model System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Preclinical CRO Market, Sub-Segmentation Of Bioanalysis and DMPK Studies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Preclinical CRO Market, Sub-Segmentation Of Toxicology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Preclinical CRO Market, Sub-Segmentation Of Compound Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Preclinical CRO Market, Sub-Segmentation Of Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Preclinical CRO Market, Sub-Segmentation Of Safety Pharmacology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Preclinical CRO Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Preclinical CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Preclinical CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Eurofins Scientific SE Financial Performance
  • Table 83: PRA Health Sciences Inc. Financial Performance
  • Table 84: Wuxi AppTec Co. Ltd. Financial Performance
  • Table 85: Medpace Holdings Inc. Financial Performance
  • Table 86: Charles River Laboratories International Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Preclinical CRO Market, Segmentation By Model System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Preclinical CRO Market, Sub-Segmentation Of Bioanalysis and DMPK Studies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Preclinical CRO Market, Sub-Segmentation Of Toxicology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Preclinical CRO Market, Sub-Segmentation Of Compound Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Preclinical CRO Market, Sub-Segmentation Of Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Preclinical CRO Market, Sub-Segmentation Of Safety Pharmacology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Preclinical CRO Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Preclinical CRO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Preclinical CRO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Eurofins Scientific SE Financial Performance
  • Figure 83: PRA Health Sciences Inc. Financial Performance
  • Figure 84: Wuxi AppTec Co. Ltd. Financial Performance
  • Figure 85: Medpace Holdings Inc. Financial Performance
  • Figure 86: Charles River Laboratories International Inc. Financial Performance

Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Read More About Strong CAGR to Propel in the Central Nervous System Lymphoma Treatment Market and Beyond upto $1.66 Billion by 2029

Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Cerebral Adrenoleukodystrophy (CALD) Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Cerebral Amyloid Angiopathy Treatment Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Chikungunya Market Trends: Regional Breakdowns and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)...

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)...

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact...

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bu...

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User ...

View Report

Medical Billing Outsourcing Global Market Report 2025 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Impact of Tariff and Trade War on Market Size, G...

View Report

Frequently Asked Questions

Preclinical CROs (contract research organizations) are support organizations that provide the knowledge in research and development needed to guide a drug candidate through animal testing and advance it to the clinical stage. A preclinical CRO supports new medical product producers in showing product safety and efficacy in living animals that the Food and Drug Administration (FDA) considers mirroring human anatomy most closely before entering clinical trials or being used for human care. For further insights on this market, request a sample here

The market major growth driver - Surging Demand For Preclinical Trials Drives Growth In The Preclinical CRO Market. For further insights on this market, request a sample here

The preclinical cro market size has grown strongly in recent years. It will grow from $5.7 billion in 2024 to $6.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to demand for faster drug development, cost containment strategies, focus on core competencies, regulatory compliance requirements, globalization of clinical trials. The preclinical cro market size is expected to see strong growth in the next few years. It will grow to " $8.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rise in personalized medicine, focus on rare diseases and orphan drugs, increased outsourcing in biopharmaceuticals, emphasis on biomarker research, demand for real-world evidence generation. Major trends in the forecast period include integration of artificial intelligence (AI), expansion of oncology research, advances in omics technologies, advanced in vitro and in vivo models, collaboration for translational research. For further insights on this market, request a sample here

The preclinical cromarket covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies; Toxicology Testing; Compound Management; Chemistry; Safety Pharmacology; Others Services
2) By Type: Patient Derived Organoid (PDO) Model; Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model; Large Animal Model
4) By Model System: In Vivo; In Vitro
5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device Companies; Other End-users Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies; Pharmacodynamics Studies; Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing; Chronic Toxicity Testing; Reproductive Toxicity Testing
3) By Compound Management: Sample Management; Inventory Management; Formulation Services
4) By Chemistry: Medicinal Chemistry; Analytical Chemistry; Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies; Central Nervous System Safety Studies; Respiratory Safety Studies
6) By Other Services: Regulatory Consulting; Project Management; Data Management Services For further insights on this market, request a sample here

North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited . For further insights on this market, request a sample here.

Major trends in this market include Revolutionizing Preclinical Drug Discovery. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Preclinical CRO Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon